112 related articles for article (PubMed ID: 3305935)
1. The proteoglycanase from human cartilage and cultured rabbit chondrocytes and its relation to osteoarthritis.
Sapolsky S; Malemud C; Sheff M
J Rheumatol; 1987 May; 14 Spec No():33-5. PubMed ID: 3305935
[TBL] [Abstract][Full Text] [Related]
2. Neutral proteinases from articular chondrocytes in culture. 2. Metal-dependent latent neutral proteoglycanase, and inhibitory activity.
Sapolsky AI; Malemud CJ; Norby DP; Moskowitz RW; Matsuta K; Howell DS
Biochim Biophys Acta; 1981 Mar; 658(1):138-47. PubMed ID: 6783102
[TBL] [Abstract][Full Text] [Related]
3. Metal-dependent neutral proteoglycanase activity from monolayer-cultured lapine articular chondrocytes.
Malemud CJ; Weitzman GA; Norby DP; Sapolsky AI; Howell DS
J Lab Clin Med; 1979 Jun; 93(6):1018-30. PubMed ID: 438603
[TBL] [Abstract][Full Text] [Related]
4. Degradative enzyme systems in osteoarthritic cartilage.
Ehrlich MG
J Orthop Res; 1985; 3(2):170-84. PubMed ID: 2987465
[TBL] [Abstract][Full Text] [Related]
5. [Hexosaminidase and alkaline phosphatase in cartilage and chondrocyte cultures obtained from normal and arthritic rabbit joints].
Mokondjimobe E; Vignon E; Hecquet C; Bourbouze R; Adolphe M
Pathol Biol (Paris); 1991 Oct; 39(8):759-62. PubMed ID: 1837075
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced inhibition of proteoglycanase activity in the Hulth-Telhag model.
Ishizue KK; Ehrlich MG; Mankin HJ
J Orthop Res; 1989; 7(6):806-11. PubMed ID: 2507757
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articular cartilage.
Richard M; Vignon E; Peschard MJ; Broquet P; Carret JP; Louisot P
FEBS Lett; 1991 Jan; 278(1):38-40. PubMed ID: 1847113
[TBL] [Abstract][Full Text] [Related]
8. [Changes in enzyme activity in cartilage and subchondral bone in experimental osteoarthrosis].
Rohozková D; Votrubová L; Tesárek B; Trnavský K
Cas Lek Cesk; 1985 Jul; 124(28):876-9. PubMed ID: 2992789
[No Abstract] [Full Text] [Related]
9. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
10. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
11. Profile of glycosaminoglycan-degrading glycosidases and glycoside sulfatases secreted by human articular chondrocytes in homeostasis and inflammation.
Shikhman AR; Brinson DC; Lotz M
Arthritis Rheum; 2000 Jun; 43(6):1307-14. PubMed ID: 10857789
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage.
Ohta S; Imai K; Yamashita K; Matsumoto T; Azumano I; Okada Y
Lab Invest; 1998 Jan; 78(1):79-87. PubMed ID: 9461124
[TBL] [Abstract][Full Text] [Related]
13. Degradative enzyme systems in cartilage.
Ehrlich MG; Armstrong AL; Treadwell BV; Mankin HJ
Clin Orthop Relat Res; 1986 Dec; (213):62-8. PubMed ID: 3022974
[TBL] [Abstract][Full Text] [Related]
14. 'Gelatinase-like' activity from articular chondrocytes in monolayer culture.
Sapolsky AI; Sheff MF; Matsuta K; Howell DS; Moskowitz RW; Goldberg VM; Norby DP; Malemud CJ
Biochim Biophys Acta; 1983 Apr; 762(2):227-31. PubMed ID: 6299387
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel chemical series that blocks interleukin-1-stimulated metalloprotease activity in chondrocytes.
Chandrasekhar S; Harvey AK; Dell CP; Ambler SJ; Smith CW
J Pharmacol Exp Ther; 1995 Jun; 273(3):1519-28. PubMed ID: 7791127
[TBL] [Abstract][Full Text] [Related]
16. Neutral proteases in human osteoarthritic synovium: quantification and characterization.
Martel-Pelletier J; Pelletier JP
J Rheumatol; 1987 May; 14 Spec No():38-40. PubMed ID: 3305937
[TBL] [Abstract][Full Text] [Related]
17. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
Yudoh K; Shishido K; Murayama H; Yano M; Matsubayashi K; Takada H; Nakamura H; Masuko K; Kato T; Nishioka K
Arthritis Rheum; 2007 Oct; 56(10):3307-18. PubMed ID: 17907184
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 activity in human osteoarthritic cartilage.
Vignon E; Mathieu P; Louisot P; Vilamitjana J; Harmand MF; Richard M
J Rheumatol Suppl; 1989 Aug; 18():35-8. PubMed ID: 2553968
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
20. Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R; Grässel S; Fuchs S; Schaumburger J; Bruckner P
Exp Cell Res; 2004 Jul; 297(2):303-12. PubMed ID: 15212936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
